Free androgen index as a determinant of arterial stiffness in menopause: A mediation analysis

Menopause

Volumn 24, Issue 6, 2017, Pages 635-644

  Lambrinoudaki, Irene ^a   Georgiopoulos, Georgios A ^b   Athanasouli, Fani ^b   Armeni, Elena ^a   Rizos, Demetrios ^a   Augoulea, Areti ^a   Chatzidou, Sofia ^b   Koutli, Evangelia ^b   Makris, Nikolaos ^b   Kanakakis, Ioannis ^b   Stamatelopoulos, Kimon ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Androgens; Arterial stiffness; FAI; Mediation; Menopause; PWV; Sex hormones

Indexed keywords

ANDROGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AORTIC PRESSURE; AORTIC PULSE PRESSURE; ARTERIAL STIFFNESS; ARTERIAL WAVE REFLECTION; ARTICLE; AUGMENTATION INDEX; BLOOD VESSEL PARAMETERS; DIASTOLIC BLOOD PRESSURE; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FREE ANDROGEN INDEX; HUMAN; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; PULSE PRESSURE; PULSE WAVE; SCANNING ELECTRON MICROSCOPY; SYSTOLIC BLOOD PRESSURE; AORTA; BLOOD; BLOOD PRESSURE; PHYSIOLOGY;

ANDROGENS; AORTA; BLOOD PRESSURE; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PULSE WAVE ANALYSIS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; VASCULAR STIFFNESS;

EID: 85011305961     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000822     Document Type: Article

References (50)

1. Vitale C, Fini M, Speziale G, Chierchia S. Gender differences in the cardiovascular effects of sex hormones. Fundam Clin Pharmacol 2010; 24: 675-685.
2. Lambrinoudaki I, Christodoulakos G, Rizos D, et al. Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women. Eur J Endocrinol 2006; 154: 907-916.
3. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005; 90: 3847-3853.
4. Mesch VR, Siseles NO, Maidana PN, et al. Androgens in relationship to cardiovascular risk factors in the menopausal transition. Climacteric 2008; 11: 509-517.
5. Golden SH, Maguire A, Ding J, et al. Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. Am J Epidemiol 2002; 155: 437-445.
6. Karim R, Hodis HN, Stanczyk FZ, Lobo RA, Mack WJ. Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab 2008; 93: 131-138.
7. Barrett-Connor E, Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ 1995; 311: 1193-1196.
8. Wildman RP, Colvin AB, Powell LH, et al. Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women'sHealthAcross theNation (SWAN). Menopause 2008; 15: 414-421.
9. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev 2003; 24: 313-340.
10. Wang L, Szklo M, Folsom AR, Cook NR, Gapstur SM, Ouyang P. Endogenous sex hormones, blood pressure change, and risk of hypertension in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2012; 224: 228-234.
11. Georgiopoulos GA, Lambrinoudaki I, Athanasouli F, et al. Free androgen index as a predictor of blood pressure progression and accelerated vascular aging in menopause. Atherosclerosis 2016; 247: 177-183.
12. Creatsa M, Armeni E, Stamatelopoulos K, et al. Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women. Metabolism 2012; 61: 193-201.
13. Phillips GB, Jing TY, Laragh JH. Serum sex hormone levels in postmenopausal women with hypertension. J Hum Hypertens 1997; 11: 523-526.
14. Haffner SM, Newcomb PA, Marcus PM, Klein BE, Klein R. Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women. Am J Epidemiol 1995; 142: 925-934.
15. Armeni E, Stamatelopoulos K, Rizos D, et al. Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype. J Hypertens 2013; 31: 1998-2004.
16. Georgiopoulos GA, Stamatelopoulos KS, Lambrinoudaki I, et al. Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors. Hypertension 2009; 54: 98-105.
17. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-1357.
18. Brandes RP. Endothelial dysfunction and hypertension. Hypertension 2014; 64: 924-928.
19. Yannoutsos A, Levy BI, Safar ME, Slama G, Blacher J. Pathophysiology of hypertension: interactions between macro and microvascular alterations through endothelial dysfunction. J Hypertens 2014; 32: 216-224.
20. Ajani UA, Ford ES. Has the risk for coronary heart disease changed among US adults? J Am Coll Cardiol 2006; 48: 1177-1182.
21. Lambrinoudaki I, Armeni E, Georgiopoulos G, et al. Subclinical atherosclerosis in menopausal women with low to medium calculated cardiovascular risk. Int J Cardiol 2013; 164: 70-76.
22. Gunzler D, Chen T, Wu P, Zhang H. Introduction to mediation analysis with structural equation modeling. Shanghai Arch Psychiatry 2013; 25: 390-394.
23. Wardlaw JM, Allerhand M, Doubal FN, et al. Vascular risk factors, largeartery atheroma, and brain white matter hyperintensities. Neurology 2014; 82: 1331-1338.
24. Gollob HF, Reichardt C. Building Time Lags Into Causal Models of Cross-sectional Data. American Statistical Association Washington, DC: Proceedings of the Social Statistics Section of the American Statistical Association; 1985: 165-170.
25. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315-2381.
26. Stamatelopoulos KS, Georgiopoulos GA, Sfikakis PP, et al. Pilot study of circulating prolactin levels and endothelial function in men with hypertension. Am J Hypertens 2011; 24: 569-573.
27. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605.
28. Goliasch G, Kleber ME, Richter B, et al. Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score. Eur Heart J 2012; 33: 2282-2289.
29. Sobel ME. Direct and indirect effects in linear structural equation models. Sociol Methods Res 1987; 16: 155-176.
30. Kline RB. Methodology in the social sciences. Principles and Practice of Structural Equation Modeling. New York: Guilford Press; 1998.
31. Sullivan GM, Feinn R. Using effect size-or why the P value is not enough. J Grad Med Educ 2012; 4: 279-282.
32. The Reference Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010; 31: 2338-2350.
33. AlGhatrif M, Strait JB, Morrell CH, et al. Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging. Hypertension 2013; 62: 934-941.
34. Akishita M, Hashimoto M, Ohike Y, et al. Association of plasma dehydroepiandrosterone-sulfate levels with endothelial function in postmenopausal women with coronary risk factors. Hypertens Res 2008; 31: 69-74.
35. Lee SJ, Lee DW, Kim KS, Lee IK. Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes. Diabetes Res Clin Pract 2001; 54(suppl 2): S81-S92.
36. Matsui S, Yasui T, Tani A, et al. Effect of ultra-low-dose estradiol and dydrogesterone on arterial stiffness in postmenopausal women. Climacteric 2014; 17: 191-196.
37. Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, Rajzer M, Jankowski P. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens 2002; 16: 509-516.
38. Safar ME. Arterial aging: hemodynamic changes and therapeutic options. Nat Rev Cardiol 2010; 7: 442-449.
39. Khoshdel AR, Thakkinstian A, Carney SL, Attia J. Estimation of an agespecific reference interval for pulse wave velocity: a meta-analysis. J Hypertens 2006; 24: 1231-1237.
40. Natoli AK, Medley TL, Ahimastos AA, et al. Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension 2005; 46: 1129-1134.
41. Bernini GP, Moretti A, Sgro M, et al. Influence of endogenous androgens on carotid wall in postmenopausal women. Menopause 2001; 8: 43-50.
42. McCrohon JA, Jessup W, Handelsman DJ, Celermajer DS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 1999; 99: 2317-2322.
43. Hutchison SJ, Sudhir K, Chou TM, et al. Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. J Am Coll Cardiol 1997; 29: 800-807.
44. Akin F, Bastemir M, Alkis E, Kaptanoglu B. SHBG levels correlate with insulin resistance in postmenopausal women. Eur J Intern Med 2009; 20: 162-167.
45. Mares P, Dauzat M, Abramovici Y. Hormone replacement therapy with estradiol valerate and cyproterone acetate: effects on endotheliumdependent vasodilatation and arterial wall compliance. Maturitas 2002; 42: 45-53.
46. Schneider HP. The role of antiandrogens in hormone replacement therapy. Climacteric 2000; 3(suppl 2): 21-27.
47. Aznaouridis K, Vlachopoulos C, Masoura K, et al. Office blood pressure is a predictor of aortic elastic properties and urinary protein excretion in subjects with white coat hypertension. Int J Cardiol 2016; 203: 98-103.
48. Miljkovic D, Perret-Guillaume C, Alla F, Salvi P, Erpelding ML, Benetos A. Correlation between peripheral blood pressure and pulse-wave velocity values in the institutionalized elderly persons 80 years of age and older: the PARTAGE study. Am J Hypertens 2013; 26: 163-173.
49. Ly LP, Handelsman DJ. Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays. Eur J Endocrinol 2005; 152: 471-478.
50. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007; 92: 405-413.